| Organism | Feature Type | Feature ID | Info | Relationship | Display | Orthologous Group | Coexpression Group |
|---|---|---|---|---|---|---|---|
| Glycine max | polypeptide | Glyma.17G126900.1.Wm82.a2.v1 | Glyma.17G126900.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) | OG0000506 | |
| Glycine max | polypeptide | Glyma.17G126900.2.Wm82.a2.v1 | Glyma.17G126900.2 | mRNA | OG0000506 | ||
| Glycine max | polypeptide | Glyma.17G184500.1.Wm82.a2.v1 | Glyma.17G184500.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) | OG0000506 | |
| Glycine max | polypeptide | Glyma.17G193000.1.Wm82.a2.v1 | Glyma.17G193000.1 | mRNA | PTHR33159:SF3 - RPM1-INTERACTING PROTEIN 4-LIKE PROTEIN (1 of 4) | OG0000506 | |
| Glycine max | polypeptide | Glyma.17G193500.1.Wm82.a2.v1 | Glyma.17G193500.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) | OG0000506 | |
| Glycine max | polypeptide | Glyma.18G011300.1.Wm82.a2.v1 | Glyma.18G011300.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) | OG0000506 | |
| Glycine max | polypeptide | Glyma.18G011300.2.Wm82.a2.v1 | Glyma.18G011300.2 | mRNA | OG0000506 | ||
| Glycine max | polypeptide | Glyma.18G075900.1.Wm82.a2.v1 | Glyma.18G075900.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) | OG0000506 | |
| Glycine max | polypeptide | Glyma.18G166800.1.Wm82.a2.v1 | Glyma.18G166800.1 | mRNA | K13456 - RPM1-interacting protein 4 (RIN4) (1 of 5) | OG0000506 | |
| Gossypium raimondii | polypeptide | Gorai.001G232400.1.v2.1 | Gorai.001G232400.1 | mRNA | K13456 - RPM1-interacting protein 4 (RIN4) (1 of 2) | OG0000506 |